Chemical companies are projected to experience revenue growth of 5-10% in the June 2025 quarter, fueled by increased order intake anticipating US tariffs and a weaker rupee boosting exports. Lower raw material prices are expected to protect margins. However, Chinese competition and geopolitical risks create a complex environment, with investors closely monitoring volume sustainability and pricing power.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600